A 0 1 0 1 O
QT 2 4 2 4 O
interval 5 13 5 13 O
corrected 14 23 14 23 O
for 24 27 24 27 O
heart 28 33 28 33 O
rate 34 38 34 38 O
using 39 44 39 44 O
the 45 48 45 48 O
Bazett 49 55 49 55 B-clinical_variable
's 55 57 55 57 I-clinical_variable
formula 58 65 58 65 I-clinical_variable
( 66 67 66 67 I-clinical_variable
QTcB 67 71 67 71 I-clinical_variable
) 71 72 71 72 I-clinical_variable
> 73 74 73 74 O
= 74 75 74 75 O
480 76 79 76 79 B-lower_bound
msec 80 84 80 84 I-lower_bound

A 0 1 85 86 O
metastatic 2 12 87 97 B-cancer
lesion 13 19 98 104 I-cancer
that 20 24 105 109 O
is 25 27 110 112 O
not 28 31 113 116 O
radioiodine 32 43 117 128 B-treatment
- 43 44 128 129 O
avid 44 48 129 133 O
on 49 51 134 136 O
a 52 53 137 138 O
diagnostic 54 64 139 149 O
radioiodine 65 76 150 161 O
scan 77 81 162 166 O
performed 82 91 167 176 O
prior 92 97 177 182 O
to 98 100 183 185 O
enrollment 101 111 186 196 O
in 112 114 197 199 O
the 115 118 200 203 O
current 119 126 204 211 O
study 127 132 212 217 O

A 0 1 218 219 O
radioiodine 2 13 220 231 B-treatment
- 13 14 231 232 O
avid 14 18 232 236 O
metastatic 19 29 237 247 B-cancer
lesion 30 36 248 254 I-cancer
which 37 42 255 260 O
remained 43 51 261 269 O
stable 52 58 270 276 O
in 59 61 277 279 O
size 62 66 280 284 O
or 67 69 285 287 O
progressed 70 80 288 298 O
despite 81 88 299 306 O
radioiodine 89 100 307 318 B-treatment
treatment 101 110 319 328 I-treatment
6 111 112 329 330 B-lower_bound
months 113 119 331 337 I-lower_bound
or 120 122 338 340 O
more 123 127 341 345 O
prior 128 133 346 351 O
to 134 136 352 354 O
entry 137 142 355 360 O
in 143 145 361 363 O
the 146 149 364 367 O
study 150 155 368 373 O
; 155 156 373 374 O
there 157 162 375 380 O
are 163 166 381 384 O
no 167 169 385 387 O
size 170 174 388 392 O
limitations 175 186 393 404 O
for 187 190 405 408 O
the 191 194 409 412 O
index 195 200 413 418 O
lesion 201 207 419 425 O
used 208 212 426 430 O
to 213 215 431 433 O
satisfy 216 223 434 441 O
this 224 228 442 446 O
entry 229 234 447 452 O
criterion 235 244 453 462 O

Able 0 4 463 467 O
to 5 7 468 470 O
swallow 8 15 471 478 O
and 16 19 479 482 O
retain 20 26 483 489 O
orally 27 33 490 496 B-treatment
- 33 34 496 497 I-treatment
administered 34 46 497 509 I-treatment
medication 47 57 510 520 I-treatment
and 58 61 521 524 O
does 62 66 525 529 O
not 67 70 530 533 O
have 71 75 534 538 O
any 76 79 539 542 O
clinically 80 90 543 553 O
significant 91 102 554 565 O
gastrointestinal 103 119 566 582 O
abnormalities 120 133 583 596 O
that 134 138 597 601 O
may 139 142 602 605 O
alter 143 148 606 611 O
absorption 149 159 612 622 O
such 160 164 623 627 O
as 165 167 628 630 O
malabsorption 168 181 631 644 B-chronic_disease
syndrome 182 190 645 653 I-chronic_disease
or 191 193 654 656 O
major 194 199 657 662 B-treatment
resection 200 209 663 672 I-treatment
of 210 212 673 675 I-treatment
the 213 216 676 679 I-treatment
stomach 217 224 680 687 I-treatment
or 225 227 688 690 O
bowels 228 234 691 697 B-treatment

Absolute 0 8 698 706 B-clinical_variable
neutrophil 9 19 707 717 I-clinical_variable
count 20 25 718 723 I-clinical_variable
( 26 27 724 725 I-clinical_variable
ANC 27 30 725 728 I-clinical_variable
) 30 31 728 729 I-clinical_variable
> 32 33 730 731 O
= 33 34 731 732 O
1.5 35 38 733 736 B-lower_bound
x 39 40 737 738 I-lower_bound
10 41 43 739 741 I-lower_bound
^ 43 44 741 742 I-lower_bound
9 44 45 742 743 I-lower_bound
/ 45 46 743 744 I-lower_bound
L 46 47 744 745 I-lower_bound

Albumin 0 7 746 753 B-clinical_variable
> 8 9 754 755 O
= 9 10 755 756 O
2.5 11 14 757 760 B-lower_bound
g 15 16 761 762 I-lower_bound
/ 16 17 762 763 I-lower_bound
dL 17 19 763 765 I-lower_bound

All 0 3 766 769 O
prior 4 9 770 775 O
treatment 10 19 776 785 B-treatment
- 19 20 785 786 O
related 20 27 786 793 O
toxicities 28 38 794 804 O
must 39 43 805 809 O
be 44 46 810 812 O
Common 47 53 813 819 B-clinical_variable
Terminology 54 65 820 831 I-clinical_variable
Criteria 66 74 832 840 I-clinical_variable
for 75 78 841 844 I-clinical_variable
Adverse 79 86 845 852 I-clinical_variable
Events 87 93 853 859 I-clinical_variable
version 94 101 860 867 I-clinical_variable
4.0 102 105 868 871 I-clinical_variable
( 106 107 872 873 I-clinical_variable
CTCAE 107 112 873 878 I-clinical_variable
v 113 114 879 880 I-clinical_variable
4.0 115 118 881 884 I-clinical_variable
) 118 119 884 885 I-clinical_variable
grade 120 125 886 891 I-clinical_variable
= 126 127 892 893 O
< 127 128 893 894 O
1 129 130 895 896 B-upper_bound

Animal 0 6 897 903 O
reproductive 7 19 904 916 O
studies 20 27 917 924 O
have 28 32 925 929 O
not 33 36 930 933 O
been 37 41 934 938 O
conducted 42 51 939 948 O
with 52 56 949 953 O
trametinib 57 67 954 964 B-treatment

Aspartate 0 9 965 974 B-clinical_variable
aminotransferase 10 26 975 991 I-clinical_variable
( 27 28 992 993 I-clinical_variable
AST 28 31 993 996 I-clinical_variable
) 31 32 996 997 I-clinical_variable
and 33 36 998 1001 O
alanine 37 44 1002 1009 B-clinical_variable
aminotransferase 45 61 1010 1026 I-clinical_variable
( 62 63 1027 1028 I-clinical_variable
ALT 63 66 1028 1031 I-clinical_variable
) 66 67 1031 1032 I-clinical_variable
= 68 69 1033 1034 O
< 69 70 1034 1035 O
2.5 71 74 1036 1039 B-upper_bound
x 75 76 1040 1041 I-upper_bound
institutional 77 90 1042 1055 I-upper_bound
ULN 91 94 1056 1059 I-upper_bound

Availability 0 12 1060 1072 O
of 13 15 1073 1075 O
archival 16 24 1076 1084 O
tumor 25 30 1085 1090 B-cancer
tissue 31 37 1091 1097 O
from 38 42 1098 1102 O
the 43 46 1103 1106 O
thyroid 47 54 1107 1114 B-cancer
cancer 55 61 1115 1121 I-cancer
primary 62 69 1122 1129 O
or 70 72 1130 1132 O
metastasis 73 83 1133 1143 B-cancer
( 84 85 1144 1145 O
a 85 86 1145 1146 O
tissue 87 93 1147 1153 O
block 94 99 1154 1159 O
or 100 102 1160 1162 O
a 103 104 1163 1164 O
minimum 105 112 1165 1172 O
of 113 115 1173 1175 O
30 116 118 1176 1178 O
unstained 119 128 1179 1188 O
slides 129 135 1189 1195 O
would 136 141 1196 1201 O
be 142 144 1202 1204 O
required 145 153 1205 1213 O
; 153 154 1213 1214 O
patients 155 163 1215 1223 O
with 164 168 1224 1228 O
less 169 173 1229 1233 O
archival 174 182 1234 1242 O
tissue 183 189 1243 1249 O
available 190 199 1250 1259 O
may 200 203 1260 1263 O
still 204 209 1264 1269 O
be 210 212 1270 1272 O
eligible 213 221 1273 1281 O
for 222 225 1282 1285 O
the 226 229 1286 1289 O
study 230 235 1290 1295 O
after 236 241 1296 1301 O
discussion 242 252 1302 1312 O
with 253 257 1313 1317 O
the 258 261 1318 1321 O
MSK 262 265 1322 1325 O
principal 266 275 1326 1335 O
investigator 276 288 1336 1348 O
) 288 289 1348 1349 O

COHORT 0 6 1350 1356 O
A 7 8 1357 1358 O
: 8 9 1358 1359 O
Confirmation 10 22 1360 1372 O
in 23 25 1373 1375 O
a 26 27 1376 1377 O
Clinical 28 36 1378 1386 O
Laboratory 37 47 1387 1397 O
Improvement 48 59 1398 1409 O
Amendments 60 70 1410 1420 O
( 71 72 1421 1422 O
CLIA 72 76 1422 1426 O
) 76 77 1426 1427 O
certified 78 87 1428 1437 O
laboratory 88 98 1438 1448 O
that 99 103 1449 1453 O
one 104 107 1454 1457 O
of 108 110 1458 1460 O
the 111 114 1461 1464 O
patient 115 122 1465 1472 O
's 122 124 1472 1474 O
thyroid 125 132 1475 1482 B-cancer
tumors 133 139 1483 1489 I-cancer
( 140 141 1490 1491 O
primary 141 148 1491 1498 B-cancer
tumor 149 154 1499 1504 I-cancer
, 154 155 1504 1505 O
recurrent 156 165 1506 1515 O
tumor 166 171 1516 1521 O
, 171 172 1521 1522 O
or 173 175 1523 1525 O
metastasis 176 186 1526 1536 B-cancer
) 186 187 1536 1537 O
has 188 191 1538 1541 O
an 192 194 1542 1544 O
neuroblastoma 195 208 1545 1558 B-cancer
RAS 209 212 1559 1562 O
viral 213 218 1563 1568 O
( 219 220 1569 1570 O
v 220 221 1570 1571 O
- 221 222 1571 1572 O
ras 222 225 1572 1575 O
) 225 226 1575 1576 O
oncogene 227 235 1577 1585 O
homolog 236 243 1586 1593 O
( 244 245 1594 1595 O
NRAS 245 249 1595 1599 O
) 249 250 1599 1600 O
or 251 253 1601 1603 O
Kirsten 254 261 1604 1611 O
rat 262 265 1612 1615 O
sarcoma 266 273 1616 1623 B-cancer
viral 274 279 1624 1629 O
oncogene 280 288 1630 1638 O
homolog 289 296 1639 1646 O
( 297 298 1647 1648 O
KRAS 298 302 1648 1652 O
) 302 303 1652 1653 O
or 304 306 1654 1656 O
Harvey 307 313 1657 1663 O
rat 314 317 1664 1667 O
sarcoma 318 325 1668 1675 O
viral 326 331 1676 1681 O
oncogene 332 340 1682 1690 O
homolog 341 348 1691 1698 O
( 349 350 1699 1700 O
HRAS 350 354 1700 1704 O
) 354 355 1704 1705 O
mutation 356 364 1706 1714 O
at 365 367 1715 1717 O
G12 368 371 1718 1721 O
, 371 372 1721 1722 O
G13 373 376 1723 1726 O
, 376 377 1726 1727 O
or 378 380 1728 1730 O
Q61 381 384 1731 1734 O
; 384 385 1734 1735 O
this 386 390 1736 1740 O
group 391 396 1741 1746 O
of 397 399 1747 1749 O
patients 400 408 1750 1758 O
will 409 413 1759 1763 O
also 414 418 1764 1768 O
be 419 421 1769 1771 O
referred 422 430 1772 1780 O
to 431 433 1781 1783 O
as 434 436 1784 1786 O
RAS 437 440 1787 1790 O
MUT 441 444 1791 1794 O

COHORT 0 6 1795 1801 O
A 7 8 1802 1803 O
: 8 9 1803 1804 O
Patients 10 18 1805 1813 O
must 19 23 1814 1818 O
have 24 28 1819 1823 O
progressive 29 40 1824 1835 B-chronic_disease
disease 41 48 1836 1843 I-chronic_disease
, 48 49 1843 1844 O
defined 50 57 1845 1852 O
as 58 60 1853 1855 O
the 61 64 1856 1859 O
presence 65 73 1860 1868 O
of 74 76 1869 1871 O
new 77 80 1872 1875 O
or 81 83 1876 1878 O
growing 84 91 1879 1886 O
lesion(s 92 100 1887 1895 O
) 100 101 1895 1896 O
on 102 104 1897 1899 O
radiologic 105 115 1900 1910 B-treatment
imaging 116 123 1911 1918 I-treatment
within 124 130 1919 1925 O
14 131 133 1926 1928 B-upper_bound
months 134 140 1929 1935 I-upper_bound
of 141 143 1936 1938 O
study 144 149 1939 1944 O
enrollment 150 160 1945 1955 O
and/or 161 167 1956 1962 O
new 168 171 1963 1966 O
/ 171 172 1966 1967 O
worsening 172 181 1967 1976 O
disease 182 189 1977 1984 O
related 190 197 1985 1992 O
symptoms 198 206 1993 2001 O
within 207 213 2002 2008 O
14 214 216 2009 2011 O
months 217 223 2012 2018 O
of 224 226 2019 2021 O
study 227 232 2022 2027 O
enrollment 233 243 2028 2038 O

Concurrent 0 10 2039 2049 B-treatment
treatment 11 20 2050 2059 I-treatment
with 21 25 2060 2064 O
bisphosphonates 26 41 2065 2080 B-treatment

Creatinine 0 10 2081 2091 B-clinical_variable
= 11 12 2092 2093 O
< 12 13 2093 2094 O
1.5 14 17 2095 2098 B-upper_bound
mg 18 20 2099 2101 I-upper_bound
/ 20 21 2101 2102 I-upper_bound
dL 21 23 2102 2104 I-upper_bound
OR 24 26 2105 2107 O
calculated 27 37 2108 2118 B-clinical_variable
creatinine 38 48 2119 2129 I-clinical_variable
clearance 49 58 2130 2139 I-clinical_variable
( 59 60 2140 2141 O
Cockcroft 60 69 2141 2150 O
- 69 70 2150 2151 O
Gault 70 75 2151 2156 O
formula 76 83 2157 2164 O
) 83 84 2164 2165 O
> 85 86 2166 2167 O
= 86 87 2167 2168 O
50 88 90 2169 2171 B-lower_bound
mL 91 93 2172 2174 I-lower_bound
/ 93 94 2174 2175 I-lower_bound
min 94 97 2175 2178 I-lower_bound
OR 98 100 2179 2181 O
24 101 103 2182 2184 O
- 103 104 2184 2185 O
hour 104 108 2185 2189 O
urine 109 114 2190 2195 O
creatinine 115 125 2196 2206 O
clearance 126 135 2207 2216 O
> 136 137 2217 2218 O
= 137 138 2218 2219 O
50 139 141 2220 2222 O
mL 142 144 2223 2225 O
/ 144 145 2225 2226 O
min 145 148 2226 2229 O

Current 0 7 2230 2237 O
use 8 11 2238 2241 O
of 12 14 2242 2244 O
a 15 16 2245 2246 O
prohibited 17 27 2247 2257 B-treatment
medication 28 38 2258 2268 I-treatment

Eastern 0 7 2269 2276 B-clinical_variable
Cooperative 8 19 2277 2288 I-clinical_variable
Oncology 20 28 2289 2297 I-clinical_variable
Group 29 34 2298 2303 I-clinical_variable
( 35 36 2304 2305 I-clinical_variable
ECOG 36 40 2305 2309 I-clinical_variable
) 40 41 2309 2310 I-clinical_variable
performance 42 53 2311 2322 I-clinical_variable
status 54 60 2323 2329 I-clinical_variable
= 61 62 2330 2331 O
< 62 63 2331 2332 O
2 64 65 2333 2334 B-upper_bound
( 66 67 2335 2336 O
Karnofsky 67 76 2336 2345 B-clinical_variable
> 77 78 2346 2347 O
= 78 79 2347 2348 O
60 80 82 2349 2351 B-lower_bound
% 82 83 2351 2352 I-lower_bound
) 83 84 2352 2353 O

HIV 0 3 2354 2357 B-chronic_disease
- 3 4 2357 2358 O
positive 4 12 2358 2366 O
patients 13 21 2367 2375 O
on 22 24 2376 2378 O
combination 25 36 2379 2390 B-treatment
antiretroviral 37 51 2391 2405 I-treatment
therapy 52 59 2406 2413 I-treatment
are 60 63 2414 2417 O
ineligible 64 74 2418 2428 O
because 75 82 2429 2436 O
of 83 85 2437 2439 O
the 86 89 2440 2443 O
potential 90 99 2444 2453 O
for 100 103 2454 2457 O
pharmacokinetic 104 119 2458 2473 B-treatment
interactions 120 132 2474 2486 I-treatment
with 133 137 2487 2491 I-treatment
trametinib 138 148 2492 2502 I-treatment

Have 0 4 2503 2507 O
a 5 6 2508 2509 O
known 7 12 2510 2515 O
immediate 13 22 2516 2525 O
or 23 25 2526 2528 O
delayed 26 33 2529 2536 O
hypersensitivity 34 50 2537 2553 O
reaction 51 59 2554 2562 O
or 60 62 2563 2565 O
idiosyncrasy 63 75 2566 2578 O
to 76 78 2579 2581 O
drugs 79 84 2582 2587 O
chemically 85 95 2588 2598 O
related 96 103 2599 2606 O
to 104 106 2607 2609 O
trametinib 107 117 2610 2620 B-allergy_name
, 117 118 2620 2621 O
or 119 121 2622 2624 O
excipients 122 132 2625 2635 B-allergy_name
or 133 135 2636 2638 O
to 136 138 2639 2641 O
dimethyl 139 147 2642 2650 B-allergy_name
sulfoxide 148 157 2651 2660 I-allergy_name
( 158 159 2661 2662 I-allergy_name
DMSO 159 163 2662 2666 I-allergy_name
) 163 164 2666 2667 I-allergy_name
or 165 167 2668 2670 O
to 168 170 2671 2673 O
thyrotropin 171 182 2674 2685 B-allergy_name
alpha 183 188 2686 2691 I-allergy_name
( 189 190 2692 2693 I-allergy_name
Thyrogen 190 198 2693 2701 I-allergy_name
) 198 199 2701 2702 I-allergy_name

Hemoglobin 0 10 2703 2713 B-clinical_variable
> 11 12 2714 2715 O
= 12 13 2715 2716 O
9 14 15 2717 2718 B-lower_bound
g 16 17 2719 2720 I-lower_bound
/ 17 18 2720 2721 I-lower_bound
dL 18 20 2721 2723 I-lower_bound

History 0 7 2724 2731 O
of 8 10 2732 2734 O
acute 11 16 2735 2740 B-chronic_disease
coronary 17 25 2741 2749 I-chronic_disease
syndromes 26 35 2750 2759 I-chronic_disease
( 36 37 2760 2761 O
including 37 46 2761 2770 O
myocardial 47 57 2771 2781 B-chronic_disease
infarction 58 68 2782 2792 I-chronic_disease
and 69 72 2793 2796 O
unstable 73 81 2797 2805 B-chronic_disease
angina 82 88 2806 2812 I-chronic_disease
) 88 89 2812 2813 O
, 89 90 2813 2814 O
coronary 91 99 2815 2823 B-treatment
angioplasty 100 111 2824 2835 I-treatment
, 111 112 2835 2836 O
or 113 115 2837 2839 O
stenting 116 124 2840 2848 B-treatment
within 125 131 2849 2855 O
6 132 133 2856 2857 B-upper_bound
months 134 140 2858 2864 I-upper_bound
prior 141 146 2865 2870 I-upper_bound
to 147 149 2871 2873 O
randomization 150 163 2874 2887 O

History 0 7 2888 2895 O
of 8 10 2896 2898 O
another 11 18 2899 2906 O
malignancy 19 29 2907 2917 B-cancer

History 0 7 2918 2925 O
of 8 10 2926 2928 O
interstitial 11 23 2929 2941 B-chronic_disease
lung 24 28 2942 2946 I-chronic_disease
disease 29 36 2947 2954 I-chronic_disease
or 37 39 2955 2957 O
pneumonitis 40 51 2958 2969 B-chronic_disease

History 0 7 2970 2977 O
or 8 10 2978 2980 O
evidence 11 19 2981 2989 O
of 20 22 2990 2992 O
cardiovascular 23 37 2993 3007 B-chronic_disease
risk 38 42 3008 3012 I-chronic_disease

History 0 7 3013 3020 O
or 8 10 3021 3023 O
evidence 11 19 3024 3032 O
of 20 22 3033 3035 O
current 23 30 3036 3043 O
> 31 32 3044 3045 O
= 32 33 3045 3046 O
class 34 39 3047 3052 O
II 40 42 3053 3055 O
congestive 43 53 3056 3066 B-chronic_disease
heart 54 59 3067 3072 I-chronic_disease
failure 60 67 3073 3080 I-chronic_disease
as 68 70 3081 3083 O
defined 71 78 3084 3091 O
by 79 81 3092 3094 O
the 82 85 3095 3098 O
New 86 89 3099 3102 B-clinical_variable
York 90 94 3103 3107 I-clinical_variable
Heart 95 100 3108 3113 I-clinical_variable
Association 101 112 3114 3125 I-clinical_variable
( 113 114 3126 3127 I-clinical_variable
NYHA 114 118 3127 3131 I-clinical_variable
) 118 119 3131 3132 I-clinical_variable
functional 120 130 3133 3143 O
classification 131 145 3144 3158 O
system 146 152 3159 3165 O

History 0 7 3166 3173 O
or 8 10 3174 3176 O
evidence 11 19 3177 3185 O
of 20 22 3186 3188 O
current 23 30 3189 3196 O
clinically 31 41 3197 3207 O
significant 42 53 3208 3219 O
uncontrolled 54 66 3220 3232 O
arrhythmias 67 78 3233 3244 B-chronic_disease

Known 0 5 3245 3250 O
cardiac 6 13 3251 3258 B-cancer
metastases 14 24 3259 3269 I-cancer

Known 0 5 3270 3275 O
human 6 11 3276 3281 B-chronic_disease
immunodeficiency 12 28 3282 3298 I-chronic_disease
virus 29 34 3299 3304 I-chronic_disease
( 35 36 3305 3306 I-chronic_disease
HIV 36 39 3306 3309 I-chronic_disease
) 39 40 3309 3310 I-chronic_disease
, 40 41 3310 3311 O
hepatitis 42 51 3312 3321 B-chronic_disease
B 52 53 3322 3323 I-chronic_disease
virus 54 59 3324 3329 I-chronic_disease
( 60 61 3330 3331 I-chronic_disease
HBV 61 64 3331 3334 I-chronic_disease
) 64 65 3334 3335 I-chronic_disease
, 65 66 3335 3336 O
or 67 69 3337 3339 O
hepatitis 70 79 3340 3349 B-chronic_disease
C 80 81 3350 3351 I-chronic_disease
virus 82 87 3352 3357 I-chronic_disease
( 88 89 3358 3359 I-chronic_disease
HCV 89 92 3359 3362 I-chronic_disease
) 92 93 3362 3363 I-chronic_disease
infection 94 103 3364 3373 O

Left 0 4 3374 3378 B-clinical_variable
ventricular 5 16 3379 3390 I-clinical_variable
ejection 17 25 3391 3399 I-clinical_variable
fraction 26 34 3400 3408 I-clinical_variable
( 35 36 3409 3410 I-clinical_variable
LVEF 36 40 3410 3414 I-clinical_variable
) 40 41 3414 3415 I-clinical_variable
< 42 43 3416 3417 O
LLN 44 47 3418 3421 O

Left 0 4 3422 3426 B-clinical_variable
ventricular 5 16 3427 3438 I-clinical_variable
ejection 17 25 3439 3447 I-clinical_variable
fraction 26 34 3448 3456 I-clinical_variable
> 35 36 3457 3458 O
= 36 37 3458 3459 O
institutional 38 51 3460 3473 O
lower 52 57 3474 3479 O
limit 58 63 3480 3485 O
of 64 66 3486 3488 O
normal 67 73 3489 3495 O
( 74 75 3496 3497 O
LLN 75 78 3497 3500 O
) 78 79 3500 3501 O
by 80 82 3502 3504 O
echocardiogram 83 97 3505 3519 B-treatment
( 98 99 3520 3521 I-treatment
ECHO 99 103 3521 3525 I-treatment
) 103 104 3525 3526 I-treatment
or 105 107 3527 3529 O
multi 108 113 3530 3535 B-treatment
gated 114 119 3536 3541 I-treatment
acquisition 120 131 3542 3553 I-treatment
scan 132 136 3554 3558 I-treatment
( 137 138 3559 3560 I-treatment
MUGA 138 142 3560 3564 I-treatment
) 142 143 3564 3565 I-treatment

Life 0 4 3566 3570 B-clinical_variable
expectancy 5 15 3571 3581 I-clinical_variable
of 16 18 3582 3584 O
greater 19 26 3585 3592 O
than 27 31 3593 3597 O
3 32 33 3598 3599 B-lower_bound
months 34 40 3600 3606 I-lower_bound

No 0 2 3607 3609 O
chemotherapy 3 15 3610 3622 B-treatment
or 16 18 3623 3625 O
targeted 19 27 3626 3634 B-treatment
therapy 28 35 3635 3642 I-treatment
( 36 37 3643 3644 O
e.g. 37 41 3644 3648 O
, 41 42 3648 3649 O
tyrosine 43 51 3650 3658 B-treatment
kinase 52 58 3659 3665 I-treatment
inhibitor 59 68 3666 3675 I-treatment
) 68 69 3675 3676 O
is 70 72 3677 3679 O
allowed 73 80 3680 3687 O
< 81 82 3688 3689 O
4 83 84 3690 3691 B-upper_bound
weeks 85 90 3692 3697 I-upper_bound
prior 91 96 3698 3703 I-upper_bound
to 97 99 3704 3706 O
the 100 103 3707 3710 O
initiation 104 114 3711 3721 O
of 115 117 3722 3724 O
therapy 118 125 3725 3732 O
on 126 128 3733 3735 O
this 129 133 3736 3740 O
protocol 134 142 3741 3749 O

No 0 2 3750 3752 O
external 3 11 3753 3761 B-treatment
beam 12 16 3762 3766 I-treatment
radiation 17 26 3767 3776 I-treatment
therapy 27 34 3777 3784 I-treatment
< 35 36 3785 3786 O
4 37 38 3787 3788 B-upper_bound
weeks 39 44 3789 3794 I-upper_bound
prior 45 50 3795 3800 I-upper_bound
to 51 53 3801 3803 O
initiation 54 64 3804 3814 O
of 65 67 3815 3817 O
therapy 68 75 3818 3825 O
on 76 78 3826 3828 O
this 79 83 3829 3833 O
protocol 84 92 3834 3842 O

No 0 2 3843 3845 O
prior 3 8 3846 3851 B-treatment
RAI 9 12 3852 3855 I-treatment
therapy 13 20 3856 3863 I-treatment
is 21 23 3864 3866 O
allowed 24 31 3867 3874 O
< 32 33 3875 3876 O
6 34 35 3877 3878 B-upper_bound
months 36 42 3879 3885 I-upper_bound
prior 43 48 3886 3891 I-upper_bound
to 49 51 3892 3894 O
initiation 52 62 3895 3905 O
of 63 65 3906 3908 O
therapy 66 73 3909 3916 O
on 74 76 3917 3919 O
this 77 81 3920 3924 O
protocol 82 90 3925 3933 O

No 0 2 3934 3936 O
recent 3 9 3937 3943 O
treatment 10 19 3944 3953 B-treatment
for 20 23 3954 3957 O
thyroid 24 31 3958 3965 B-cancer
cancer 32 38 3966 3972 I-cancer

Other 0 5 3973 3978 B-treatment
anti 6 10 3979 3983 I-treatment
- 10 11 3983 3984 I-treatment
cancer 11 17 3984 3990 I-treatment
therapy 18 25 3991 3998 O
while 26 31 3999 4004 O
on 32 34 4005 4007 O
study 35 40 4008 4013 O

Patients 0 8 4014 4022 O
must 9 13 4023 4027 O
agree 14 19 4028 4033 O
to 20 22 4034 4036 O
undergo 23 30 4037 4044 O
two 31 34 4045 4048 O
separate 35 43 4049 4057 O
biopsies 44 52 4058 4066 B-treatment
of 53 55 4067 4069 O
a 56 57 4070 4071 O
malignant 58 67 4072 4081 O
lesion 68 74 4082 4088 O

Patients 0 8 4089 4097 O
must 9 13 4098 4102 O
have 14 18 4103 4107 O
histologically 19 33 4108 4122 O
or 34 36 4123 4125 O
cytologically 37 50 4126 4139 O
confirmed 51 60 4140 4149 O
thyroid 61 68 4150 4157 B-cancer
carcinoma 69 78 4158 4167 I-cancer
of 79 81 4168 4170 O
follicular 82 92 4171 4181 O
origin 93 99 4182 4188 O
( 100 101 4189 4190 O
including 101 110 4190 4199 O
papillary 111 120 4200 4209 O
, 120 121 4209 4210 O
follicular 122 132 4211 4221 O
, 132 133 4221 4222 O
or 134 136 4223 4225 O
poorly 137 143 4226 4232 O
differentiated 144 158 4233 4247 O
subtypes 159 167 4248 4256 O
and 168 171 4257 4260 O
their 172 177 4261 4266 O
respective 178 188 4267 4277 O
variants 189 197 4278 4286 O
) 197 198 4286 4287 O
; 198 199 4287 4288 O
confirmation 200 212 4289 4301 O
of 213 215 4302 4304 O
thyroid 216 223 4305 4312 O
carcinoma 224 233 4313 4322 O
will 234 238 4323 4327 O
be 239 241 4328 4330 O
done 242 246 4331 4335 O
at 247 249 4336 4338 O
Memorial 250 258 4339 4347 O
Sloan 259 264 4348 4353 O
- 264 265 4353 4354 O
Kettering 265 274 4354 4363 O
( 275 276 4364 4365 O
MSK 276 279 4365 4368 O
) 279 280 4368 4369 O

Patients 0 8 4370 4378 O
must 9 13 4379 4383 O
have 14 18 4384 4388 O
measurable 19 29 4389 4399 O
disease 30 37 4400 4407 O
, 37 38 4407 4408 O
defined 39 46 4409 4416 O
as 47 49 4417 4419 O
at 50 52 4420 4422 O
least 53 58 4423 4428 O
one 59 62 4429 4432 B-lower_bound
lesion 63 69 4433 4439 O
that 70 74 4440 4444 O
can 75 78 4445 4448 O
be 79 81 4449 4451 O
accurately 82 92 4452 4462 O
measured 93 101 4463 4471 O
in 102 104 4472 4474 O
at 105 107 4475 4477 O
least 108 113 4478 4483 O
one 114 117 4484 4487 O
dimension 118 127 4488 4497 O
( 128 129 4498 4499 O
longest 129 136 4499 4506 O
diameter 137 145 4507 4515 O
to 146 148 4516 4518 O
be 149 151 4519 4521 O
recorded 152 160 4522 4530 O
for 161 164 4531 4534 O
non 165 168 4535 4538 O
- 168 169 4538 4539 O
nodal 169 174 4539 4544 O
lesions 175 182 4545 4552 O
and 183 186 4553 4556 O
short 187 192 4557 4562 O
axis 193 197 4563 4567 O
for 198 201 4568 4571 O
nodal 202 207 4572 4577 O
lesions 208 215 4578 4585 O
) 215 216 4585 4586 O
as 217 219 4587 4589 O
> 220 221 4590 4591 O
= 221 222 4591 4592 O
20 223 225 4593 4595 B-lower_bound
mm 226 228 4596 4598 I-lower_bound
with 229 233 4599 4603 O
conventional 234 246 4604 4616 B-treatment
techniques 247 257 4617 4627 I-treatment
or 258 260 4628 4630 O
as 261 263 4631 4633 O
> 264 265 4634 4635 O
= 265 266 4635 4636 O
10 267 269 4637 4639 B-lower_bound
mm 270 272 4640 4642 I-lower_bound
with 273 277 4643 4647 O
spiral 278 284 4648 4654 B-treatment
CT 285 287 4655 4657 I-treatment
scan 288 292 4658 4662 I-treatment
, 292 293 4662 4663 O
magnetic 294 302 4664 4672 B-treatment
resonance 303 312 4673 4682 I-treatment
imaging 313 320 4683 4690 I-treatment
( 321 322 4691 4692 I-treatment
MRI 322 325 4692 4695 I-treatment
) 325 326 4695 4696 I-treatment
, 326 327 4696 4697 O
or 328 330 4698 4700 O
calipers 331 339 4701 4709 B-treatment
by 340 342 4710 4712 O
clinical 343 351 4713 4721 O
exam 352 356 4722 4726 O

Patients 0 8 4727 4735 O
unable 9 15 4736 4742 O
to 16 18 4743 4745 O
follow 19 25 4746 4752 O
a 26 27 4753 4754 O
low 28 31 4755 4758 O
iodine 32 38 4759 4765 O
diet 39 43 4766 4770 O
or 44 46 4771 4773 O
requiring 47 56 4774 4783 O
medication 57 67 4784 4794 B-treatment
with 68 72 4795 4799 O
high 73 77 4800 4804 O
content 78 85 4805 4812 O
in 86 88 4813 4815 O
iodide 89 95 4816 4822 O
( 96 97 4823 4824 O
amiodarone 97 107 4824 4834 B-treatment
) 107 108 4834 4835 O

Patients 0 8 4836 4844 O
who 9 12 4845 4848 O
received 13 21 4849 4857 O
iodinated 22 31 4858 4867 B-treatment
intravenous 32 43 4868 4879 I-treatment
contrast 44 52 4880 4888 I-treatment
as 53 55 4889 4891 O
part 56 60 4892 4896 O
of 61 63 4897 4899 O
a 64 65 4900 4901 O
radiographic 66 78 4902 4914 B-treatment
procedure 79 88 4915 4924 I-treatment
within 89 95 4925 4931 O
3 96 97 4932 4933 B-upper_bound
months 98 104 4934 4940 I-upper_bound
of 105 107 4941 4943 O
study 108 113 4944 4949 O
registration 114 126 4950 4962 O

Patients 0 8 4963 4971 O
with 9 13 4972 4976 O
intra 14 19 4977 4982 B-treatment
- 19 20 4982 4983 I-treatment
cardiac 20 27 4983 4990 I-treatment
defibrillators 28 42 4991 5005 I-treatment

Platelets 0 9 5006 5015 B-clinical_variable
> 10 11 5016 5017 O
= 11 12 5017 5018 O
100 13 16 5019 5022 B-lower_bound
x 17 18 5023 5024 I-lower_bound
10 19 21 5025 5027 I-lower_bound
^ 21 22 5027 5028 I-lower_bound
9 22 23 5028 5029 I-lower_bound
/ 23 24 5029 5030 I-lower_bound
L 24 25 5030 5031 I-lower_bound

Prothrombin 0 11 5032 5043 B-clinical_variable
time 12 16 5044 5048 I-clinical_variable
( 17 18 5049 5050 I-clinical_variable
PT)/international 18 35 5050 5067 I-clinical_variable
normalized 36 46 5068 5078 I-clinical_variable
ratio 47 52 5079 5084 I-clinical_variable
( 53 54 5085 5086 I-clinical_variable
INR 54 57 5086 5089 I-clinical_variable
) 57 58 5089 5090 I-clinical_variable
and 59 62 5091 5094 O
partial 63 70 5095 5102 B-clinical_variable
thromboplastin 71 85 5103 5117 I-clinical_variable
time 86 90 5118 5122 I-clinical_variable
( 91 92 5123 5124 I-clinical_variable
PTT 92 95 5124 5127 I-clinical_variable
) 95 96 5127 5128 I-clinical_variable
= 97 98 5129 5130 O
< 98 99 5130 5131 O
1.5 100 103 5132 5135 B-upper_bound
x 104 105 5136 5137 I-upper_bound
institutional 106 119 5138 5151 I-upper_bound
ULN 120 123 5152 5155 I-upper_bound

RAI 0 3 5156 5159 B-treatment
- 3 4 5159 5160 O
refractory 4 14 5160 5170 O
disease 15 22 5171 5178 O
on 23 25 5179 5181 O
structural 26 36 5182 5192 O
imaging 37 44 5193 5200 O

Symptomatic 0 11 5201 5212 O
or 12 14 5213 5215 O
untreated 15 24 5216 5225 O
leptomeningeal 25 39 5226 5240 B-cancer
or 40 42 5241 5243 O
brain 43 48 5244 5249 B-cancer
metastases 49 59 5250 5260 I-cancer
or 60 62 5261 5263 O
spinal 63 69 5264 5270 B-chronic_disease
cord 70 74 5271 5275 I-chronic_disease
compression 75 86 5276 5287 I-chronic_disease

The 0 3 5288 5291 O
goal 4 8 5292 5296 O
will 9 13 5297 5301 O
be 14 16 5302 5304 O
to 17 19 5305 5307 O
have 20 24 5308 5312 O
a 25 26 5313 5314 O
minimum 27 34 5315 5322 O
of 35 37 5323 5325 O
6 38 39 5326 5327 B-lower_bound
patients 40 48 5328 5336 O
from 49 53 5337 5341 O
Cohort 54 60 5342 5348 O
A 61 62 5349 5350 O
and 63 66 5351 5354 O
3 67 68 5355 5356 O
patients 69 77 5357 5365 O
from 78 82 5366 5370 O
Cohort 83 89 5371 5377 O
B 90 91 5378 5379 O
attempt 92 99 5380 5387 O
to 100 102 5388 5390 O
have 103 107 5391 5395 O
one 108 111 5396 5399 O
or 112 114 5400 5402 O
both 115 119 5403 5407 O
of 120 122 5408 5410 O
these 123 128 5411 5416 O
research 129 137 5417 5425 B-treatment
biopsies 138 146 5426 5434 I-treatment
done 147 151 5435 5439 O
( 152 153 5440 5441 O
for 153 156 5441 5444 O
a 157 158 5445 5446 O
total 159 164 5447 5452 O
of 165 167 5453 5455 O
9 168 169 5456 5457 O
patients 170 178 5458 5466 O
total 179 184 5467 5472 O
) 184 185 5472 5473 O
; 185 186 5473 5474 O
accrual 187 194 5475 5482 O
may 195 198 5483 5486 O
be 199 201 5487 5489 O
limited 202 209 5490 5497 O
only 210 214 5498 5502 O
to 215 217 5503 5505 O
subjects 218 226 5506 5514 O
for 227 230 5515 5518 O
whom 231 235 5519 5523 O
tumor 236 241 5524 5529 B-cancer
is 242 244 5530 5532 O
accessible 245 255 5533 5543 O
for 256 259 5544 5547 O
biopsy 260 266 5548 5554 B-treatment
and 267 270 5555 5558 O
attempt 271 278 5559 5566 O
at 279 281 5567 5569 O
biopsy 282 288 5570 5576 O
is 289 291 5577 5579 O
considered 292 302 5580 5590 O
safe 303 307 5591 5595 O
if 308 310 5596 5598 O
continued 311 320 5599 5608 O
enrollment 321 331 5609 5619 O
of 332 334 5620 5622 O
those 335 340 5623 5628 O
who 341 344 5629 5632 O
are 345 348 5633 5636 O
not 349 352 5637 5640 O
candidates 353 363 5641 5651 O
for 364 367 5652 5655 O
biopsy 368 374 5656 5662 O
make 375 379 5663 5667 O
it 380 382 5668 5670 O
impossible 383 393 5671 5681 O
to 394 396 5682 5684 O
reach 397 402 5685 5690 O
the 403 406 5691 5694 O
accrual 407 414 5695 5702 O
goals 415 420 5703 5708 O
for 421 424 5709 5712 O
research 425 433 5713 5721 O
biopsies 434 442 5722 5730 O
described 443 452 5731 5740 O
above 453 458 5741 5746 O
( 459 460 5747 5748 O
e.g. 460 464 5748 5752 O
, 464 465 5752 5753 O
if 466 468 5754 5756 O
19 469 471 5757 5759 O
[ 472 473 5760 5761 O
of 473 475 5761 5763 O
25 476 478 5764 5766 O
] 478 479 5766 5767 O
patients 480 488 5768 5776 O
are 489 492 5777 5780 O
accrued 493 500 5781 5788 O
to 501 503 5789 5791 O
Cohort 504 510 5792 5798 O
A 511 512 5799 5800 O
without 513 520 5801 5808 O
any 521 524 5809 5812 O
biopsies 525 533 5813 5821 O
having 534 540 5822 5828 O
been 541 545 5829 5833 O
obtained 546 554 5834 5842 O
within 555 561 5843 5849 O
the 562 565 5850 5853 O
cohort 566 572 5854 5860 O
, 572 573 5860 5861 O
then 574 578 5862 5866 O
all 579 582 5867 5870 O
further 583 590 5871 5878 O
subjects 591 599 5879 5887 O
who 600 603 5888 5891 O
are 604 607 5892 5895 O
registered 608 618 5896 5906 O
to 619 621 5907 5909 O
that 622 626 5910 5914 O
cohort 627 633 5915 5921 O
must 634 638 5922 5926 O
qualify 639 646 5927 5934 O
for 647 650 5935 5938 O
attempted 651 660 5939 5948 O
research 661 669 5949 5957 B-treatment
biopsy 670 676 5958 5964 I-treatment
in 677 679 5965 5967 O
order 680 685 5968 5973 O
to 686 688 5974 5976 O
be 689 691 5977 5979 O
enrolled 692 700 5980 5988 O
into 701 705 5989 5993 O
the 706 709 5994 5997 O
study 710 715 5998 6003 O

The 0 3 6004 6007 O
presence 4 12 6008 6016 O
of 13 15 6017 6019 O
at 16 18 6020 6022 O
least 19 24 6023 6028 O
one 25 28 6029 6032 B-lower_bound
fluorodeoxyglucose 29 47 6033 6051 B-treatment
( 48 49 6052 6053 I-treatment
FDG 49 52 6053 6056 I-treatment
) 52 53 6056 6057 I-treatment
avid 54 58 6058 6062 O
lesion 59 65 6063 6069 O

Total 0 5 6070 6075 B-clinical_variable
bilirubin 6 15 6076 6085 I-clinical_variable
= 16 17 6086 6087 O
< 17 18 6087 6088 O
1.5 19 22 6089 6092 B-upper_bound
x 23 24 6093 6094 I-upper_bound
institutional 25 38 6095 6108 I-upper_bound
upper 39 44 6109 6114 I-upper_bound
limit 45 50 6115 6120 I-upper_bound
of 51 53 6121 6123 I-upper_bound
normal 54 60 6124 6130 I-upper_bound
( 61 62 6131 6132 I-upper_bound
ULN 62 65 6132 6135 I-upper_bound
) 65 66 6135 6136 I-upper_bound

Treatment 0 9 6137 6146 B-treatment
- 9 10 6146 6147 I-treatment
refractory 10 20 6147 6157 I-treatment
hypertension 21 33 6158 6170 I-treatment
defined 34 41 6171 6178 O
as 42 44 6179 6181 O
a 45 46 6182 6183 O
blood 47 52 6184 6189 B-clinical_variable
pressure 53 61 6190 6198 I-clinical_variable
of 62 64 6199 6201 I-clinical_variable
systolic 65 73 6202 6210 I-clinical_variable
> 74 75 6211 6212 O
140 76 79 6213 6216 B-lower_bound
mmHg 80 84 6217 6221 I-lower_bound
and/or 85 91 6222 6228 O
diastolic 92 101 6229 6238 B-clinical_variable
> 102 103 6239 6240 O
90 104 106 6241 6243 B-lower_bound
mmHg 107 111 6244 6248 I-lower_bound
which 112 117 6249 6254 O
can 118 121 6255 6258 O
not 121 124 6258 6261 O
be 125 127 6262 6264 O
controlled 128 138 6265 6275 O
by 139 141 6276 6278 O
anti 142 146 6279 6283 B-treatment
- 146 147 6283 6284 I-treatment
hypertensive 147 159 6284 6296 I-treatment
therapy 160 167 6297 6304 I-treatment

Uncontrolled 0 12 6305 6317 O
intercurrent 13 25 6318 6330 B-chronic_disease
illness 26 33 6331 6338 I-chronic_disease
including 34 43 6339 6348 O
, 43 44 6348 6349 O
but 45 48 6350 6353 O
not 49 52 6354 6357 O
limited 53 60 6358 6365 O
to 61 63 6366 6368 O
, 63 64 6368 6369 O
ongoing 65 72 6370 6377 O
or 73 75 6378 6380 O
active 76 82 6381 6387 B-chronic_disease
infection 83 92 6388 6397 I-chronic_disease
, 92 93 6397 6398 O
symptomatic 94 105 6399 6410 O
congestive 106 116 6411 6421 B-chronic_disease
heart 117 122 6422 6427 I-chronic_disease
failure 123 130 6428 6435 I-chronic_disease
, 130 131 6435 6436 O
unstable 132 140 6437 6445 O
angina 141 147 6446 6452 B-chronic_disease
pectoris 148 156 6453 6461 I-chronic_disease
, 156 157 6461 6462 O
cardiac 158 165 6463 6470 O
arrhythmia 166 176 6471 6481 B-chronic_disease
, 176 177 6481 6482 O
or 178 180 6483 6485 O
psychiatric 181 192 6486 6497 B-chronic_disease
illness 193 200 6498 6505 I-chronic_disease
/ 200 201 6505 6506 O
social 201 207 6506 6512 O
situations 208 218 6513 6523 O
that 219 223 6524 6528 O
would 224 229 6529 6534 O
limit 230 235 6535 6540 O
compliance 236 246 6541 6551 O
with 247 251 6552 6556 O
study 252 257 6557 6562 O
requirements 258 270 6563 6575 O

Use 0 3 6576 6579 O
of 4 6 6580 6582 O
other 7 12 6583 6588 B-treatment
investigational 13 28 6589 6604 I-treatment
drugs 29 34 6605 6610 I-treatment
within 35 41 6611 6617 O
28 42 44 6618 6620 B-upper_bound
days 45 49 6621 6625 I-upper_bound
( 50 51 6626 6627 O
or 51 53 6627 6629 O
five 54 58 6630 6634 B-upper_bound
half 59 63 6635 6639 I-upper_bound
- 63 64 6639 6640 I-upper_bound
lives 64 69 6640 6645 I-upper_bound
, 69 70 6645 6646 O
whichever 71 80 6647 6656 O
is 81 83 6657 6659 O
shorter 84 91 6660 6667 O
; 91 92 6667 6668 O
with 93 97 6669 6673 O
a 98 99 6674 6675 O
minimum 100 107 6676 6683 O
of 108 110 6684 6686 O
14 111 113 6687 6689 B-lower_bound
days 114 118 6690 6694 I-lower_bound
from 119 123 6695 6699 O
the 124 127 6700 6703 O
last 128 132 6704 6708 O
dose 133 137 6709 6713 O
) 137 138 6713 6714 O
preceding 139 148 6715 6724 O
the 149 152 6725 6728 O
first 153 158 6729 6734 O
dose 159 163 6735 6739 O
of 164 166 6740 6742 O
trametinib 167 177 6743 6753 B-treatment
and 178 181 6754 6757 O
during 182 188 6758 6764 O
the 189 192 6765 6768 O
study 193 198 6769 6774 O

alopecia 0 8 6775 6783 B-chronic_disease

chronic 0 7 6784 6791 O
or 8 10 6792 6794 O
cleared 11 18 6795 6802 O
HBV 19 22 6803 6806 B-chronic_disease
and 23 26 6807 6810 O
HCV 27 30 6811 6814 B-chronic_disease
infection 31 40 6815 6824 B-chronic_disease

grade 0 5 6825 6830 O
2 6 7 6831 6832 O
prior 8 13 6833 6838 B-treatment
treatment 14 23 6839 6848 I-treatment
related 24 31 6849 6856 O
toxicities 32 42 6857 6867 O
may 43 46 6868 6871 O
be 47 49 6872 6874 O
allowed 50 57 6875 6882 O
after 58 63 6883 6888 O
discussion 64 74 6889 6899 O
with 75 79 6900 6904 O
the 80 83 6905 6908 O
principal 84 93 6909 6918 O
investigator 94 106 6919 6931 O

megestrol 0 9 6932 6941 B-treatment
[ 10 11 6942 6943 I-treatment
Megace 11 17 6943 6949 I-treatment
] 17 18 6949 6950 I-treatment
if 19 21 6951 6953 O
used 22 26 6954 6958 O
as 27 29 6959 6961 O
an 30 32 6962 6964 O
appetite 33 41 6965 6973 O
stimulant 42 51 6974 6983 O

men 0 3 6984 6987 B-gender
treated 4 11 6988 6995 O
or 12 14 6996 6998 O
enrolled 15 23 6999 7007 O
on 24 26 7008 7010 O
this 27 31 7011 7015 O
protocol 32 40 7016 7024 O
must 41 45 7025 7029 O
also 46 50 7030 7034 O
agree 51 56 7035 7040 B-contraception_consent
to 57 59 7041 7043 I-contraception_consent
use 60 63 7044 7047 I-contraception_consent
adequate 64 72 7048 7056 I-contraception_consent
contraception 73 86 7057 7070 I-contraception_consent
prior 87 92 7071 7076 O
to 93 95 7077 7079 O
the 96 99 7080 7083 O
study 100 105 7084 7089 O
, 105 106 7089 7090 O
for 107 110 7091 7094 O
the 111 114 7095 7098 O
duration 115 123 7099 7107 O
of 124 126 7108 7110 O
study 127 132 7111 7116 O
participation 133 146 7117 7130 O
, 146 147 7130 7131 O
and 148 151 7132 7135 O
4 152 153 7136 7137 B-upper_bound
months 154 160 7138 7144 I-upper_bound
after 161 166 7145 7150 I-upper_bound
completion 167 177 7151 7161 O
of 178 180 7162 7164 O
trametinib 181 191 7165 7175 B-treatment
administration 192 206 7176 7190 O

palliative 0 10 7191 7201 B-treatment
radiation 11 20 7202 7211 I-treatment
therapy 21 28 7212 7219 I-treatment
to 29 31 7220 7222 O
non 32 35 7223 7226 O
- 35 36 7226 7227 O
target 36 42 7227 7233 O
lesions 43 50 7234 7241 O

patients 0 8 7242 7250 O
who 9 12 7251 7254 O
have 13 17 7255 7259 O
been 18 22 7260 7264 O
disease 23 30 7265 7272 O
- 30 31 7272 7273 O
free 31 35 7273 7277 O
for 36 39 7278 7281 O
3 40 41 7282 7283 B-upper_bound
years 42 47 7284 7289 I-upper_bound

patients 0 8 7290 7298 O
with 9 13 7299 7303 O
a 14 15 7304 7305 O
history 16 23 7306 7313 O
of 24 26 7314 7316 O
completely 27 37 7317 7327 O
resected 38 46 7328 7336 O
non 47 50 7337 7340 B-cancer
- 50 51 7340 7341 I-cancer
melanoma 51 59 7341 7349 I-cancer
skin 60 64 7350 7354 I-cancer
cancer 65 71 7355 7361 I-cancer

patients 0 8 7362 7370 O
with 9 13 7371 7375 O
controlled 14 24 7376 7386 O
atrial 25 31 7387 7393 B-clinical_variable
fibrillation 32 44 7394 7406 I-clinical_variable
for 45 48 7407 7410 O
> 49 50 7411 7412 O
30 51 53 7413 7415 B-lower_bound
days 54 58 7416 7420 I-lower_bound
prior 59 64 7421 7426 I-lower_bound
to 65 67 7427 7429 O
randomization 68 81 7430 7443 B-treatment

patients 0 8 7444 7452 O
with 9 13 7453 7457 O
indolent 14 22 7458 7466 O
secondary 23 32 7467 7476 B-cancer
malignancies 33 45 7477 7489 I-cancer

pregnant 0 8 7490 7498 B-pregnancy
women 9 14 7499 7504 B-gender

prophylactic 0 12 7505 7517 O
use 13 16 7518 7521 O
of 17 19 7522 7524 O
bisphosphonates 20 35 7525 7540 B-treatment
in 36 38 7541 7543 O
patients 39 47 7544 7552 O
without 48 55 7553 7560 O
bone 56 60 7561 7565 B-chronic_disease
disease 61 68 7566 7573 I-chronic_disease

subjects 0 8 7574 7582 O
who 9 12 7583 7586 O
would 13 18 7587 7592 O
have 19 23 7593 7597 O
been 24 28 7598 7602 O
excluded 29 37 7603 7611 O
from 38 42 7612 7616 O
having 43 49 7617 7623 O
biopsies 50 58 7624 7632 B-treatment
done 59 63 7633 7637 O
due 64 67 7638 7641 O
to 68 70 7642 7644 O
the 71 74 7645 7648 O
above 75 80 7649 7654 O
reasons 81 88 7655 7662 O

these 0 5 7663 7668 O
potential 6 15 7669 7678 O
risks 16 21 7679 7684 O
may 22 25 7685 7688 O
also 26 30 7689 7693 O
apply 31 36 7694 7699 O
to 37 39 7700 7702 O
RAI 40 43 7703 7706 B-treatment
and 44 47 7707 7710 O
thyrogen 48 56 7711 7719 B-treatment

thyroid 0 7 7720 7727 B-clinical_variable
- 7 8 7727 7728 I-clinical_variable
stimulating 8 19 7728 7739 I-clinical_variable
hormone 20 27 7740 7747 I-clinical_variable
[ 28 29 7748 7749 I-clinical_variable
TSH 29 32 7749 7752 I-clinical_variable
] 32 33 7752 7753 I-clinical_variable
suppressive 34 45 7754 7765 B-treatment
therapy 46 53 7766 7773 I-treatment

treatment 0 9 7774 7783 B-treatment
of 10 12 7784 7786 O
osteoporosis 13 25 7787 7799 B-chronic_disease

women 0 5 7800 7805 B-gender
of 6 8 7806 7808 O
child 9 14 7809 7814 O
- 14 15 7814 7815 O
bearing 15 22 7815 7822 O
potential 23 32 7823 7832 O
and 33 36 7833 7836 O
men 37 40 7837 7840 O
must 41 45 7841 7845 O
agree 46 51 7846 7851 B-contraception_consent
to 52 54 7852 7854 I-contraception_consent
use 55 58 7855 7858 I-contraception_consent
adequate 59 67 7859 7867 I-contraception_consent
contraception 68 81 7868 7881 I-contraception_consent
( 82 83 7882 7883 O
hormonal 83 91 7883 7891 B-contraception_consent
or 92 94 7892 7894 O
barrier 95 102 7895 7902 B-contraception_consent
method 103 109 7903 7909 I-contraception_consent
of 110 112 7910 7912 I-contraception_consent
birth 113 118 7913 7918 I-contraception_consent
control 119 126 7919 7926 I-contraception_consent
; 126 127 7926 7927 O
abstinence 128 138 7928 7938 B-contraception_consent
) 138 139 7938 7939 O
prior 140 145 7940 7945 O
to 146 148 7946 7948 O
study 149 154 7949 7954 O
entry 155 160 7955 7960 O
and 161 164 7961 7964 O
for 165 168 7965 7968 O
the 169 172 7969 7972 O
duration 173 181 7973 7981 O
of 182 184 7982 7984 O
study 185 190 7985 7990 O
participation 191 204 7991 8004 O

women 0 5 8005 8010 B-gender
of 6 8 8011 8013 O
child 9 14 8014 8019 O
- 14 15 8019 8020 O
bearing 15 22 8020 8027 O
potential 23 32 8028 8037 O
must 33 37 8038 8042 O
have 38 42 8043 8047 O
a 43 44 8048 8049 O
negative 45 53 8050 8058 B-pregnancy
pregnancy 54 63 8059 8068 I-pregnancy
test 64 68 8069 8073 O
within 69 75 8074 8080 O
2 76 77 8081 8082 B-upper_bound
weeks 78 83 8083 8088 I-upper_bound
prior 84 89 8089 8094 I-upper_bound
study 90 95 8095 8100 O
registration 96 108 8101 8113 O

